Book contents
- Pediatric Pathology of Hematopoietic and Histiocytic Disorders
- Pediatric Pathology of Hematopoietic and Histiocytic Disorders
- Copyright page
- Epigraph
- Contents
- Contributors
- Section I General Hematology and Hematopathology
- Section II Non-Neoplastic Hematologic Disorders of Blood and Bone Marrow
- Section III Non-Neoplastic Disorders of Extramedullary Lymphoid Tissues
- Section IV Neoplastic Disorders of Bone Marrow
- Section V Mature Lymphoid Neoplasms
- Section VI Histiocytic Disorders and Neoplasms
- Index
- References
Section III - Non-Neoplastic Disorders of Extramedullary Lymphoid Tissues
Published online by Cambridge University Press: 25 January 2024
Book contents
- Pediatric Pathology of Hematopoietic and Histiocytic Disorders
- Pediatric Pathology of Hematopoietic and Histiocytic Disorders
- Copyright page
- Epigraph
- Contents
- Contributors
- Section I General Hematology and Hematopathology
- Section II Non-Neoplastic Hematologic Disorders of Blood and Bone Marrow
- Section III Non-Neoplastic Disorders of Extramedullary Lymphoid Tissues
- Section IV Neoplastic Disorders of Bone Marrow
- Section V Mature Lymphoid Neoplasms
- Section VI Histiocytic Disorders and Neoplasms
- Index
- References
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2024
References
References
Proytcheva, MA. Reactive lymphadenopathies. In: Proytcheva, MA, ed. Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:142–81.Google Scholar
Utz, GL, Swerdlow, SH. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies. Hum Pathol. 1993;24:1155–8.Google Scholar
Hicks, J, Flaitz, C. Progressive transformation of germinal centers: review of histopathologic and clinical features. Int J Pediatr Otohinolaryngol. 2002;65:195–202.Google Scholar
O’Malley, DP, George, TI, Orazi, A, Abbondanzo, SL. Specific clinical entities. In: Benign and reactive conditions of lymph node and spleen, atlas of nontumor pathology. Washington, DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2009:143–83.Google Scholar
Shapira, Y, Weinberger, A, Wysenbeek, AJ. Lymphaenopathy in systemic lupus. Prevalence and relation to disease manifestations. Clin Rheumatol. 1996;15:335–8.Google Scholar
O’Malley, DP, George, TI, Orazi, A, Abbondanzo, SL. Systemic and autoimmune abnormalities. In: Benign and reactive conditions of lymph node and spleen, atlas of nontumor pathology., Washington, DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2009:375–404.Google Scholar
Sopfe, J, Endres, A, Campbell, K, et al. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study. Pediatr Blood Cancer. 2019;66(5):e27613. doi: 10.1002/pbc.27613.Google Scholar
Liu, AY, Nabel, CS, Finkelman, BS, et al. Idiopathic multicentric Castleman’s disease: a systematic literature review. Lancet Haematol. 2016;3:e163–75.Google Scholar
Chang, KC, Wang, YC, Hung, LY, et al. Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease. Mod Pathol. 2014;27:823–31.Google Scholar
Fajgenbaum, DC, Shilling, D. Castleman disease pathogenesis. Hematol Oncol Clin North Am. 2018;32:11–21.Google Scholar
Al-Maghrabi, J, Kamel-Reid, S, Bailey, D. Immunoglobulin and T-cell receptor gene rearrangement in Castleman’s disease: molecular genetic analysis. Histopathology. 2006;48:233–8.Google Scholar
Oksenhendler, E, Boutboul, D, Fajgenbaum, D, et al. The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol. 2018;180:206–16.Google Scholar
Shetty, AK, Beaty, MW, McGuirt WF, Jr., et al. Kimura’s disease: a diagnostic challenge. Pediatrics. 2002;110:e39.Google Scholar
Markatis, E, Afthinos, A, Antonakis, E, Papanikolaou, IC. Cardiac sarcoidosis: diagnosis and management. Rev Cardiovasc Med. 2020;21:321–38.Google Scholar
Garces, S, Yin, CC, Miranda, RN, et al. Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update. Mod Pathol. 2020;33:1104–21.Google Scholar
Bride, K, Teachey, D. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. F1000Res. 2017;6:1928. doi: 10.12688/f1000research.11545.1. eCollection 2017.Google Scholar
Onciu, M, van Krieken, JH. Auto-immune lymphoproliferative syndrome. In: Proytcheva, MA, ed. Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:494–7.Google Scholar
Price, S, Shaw, PA, Seitz, A, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014;123:1989–99.Google Scholar
Oliveira, JB, Bleesing, JJ, Dianzani, U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:e35–40.Google Scholar
Teachey, DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr. 2012;24:1–8.Google Scholar
Shimosato, Y, Mukai, K, Matsuno, Y. Thymic hyperplasia. In: Tumors of the Mediastinum, atlas of nontumor pathology. Washington DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2010:274–80.Google Scholar
Kurtin, P. Thymus gland. In: Collins, RD, Swerdlow, SH, eds. Pediatric hematopathology. New York: Churchill Livingstone;2001:323–41.Google Scholar
References
Krishnan, J, Danon, AD, Frizzera, G. Reactive lymphadenopathies and atypical lymphoproliferative disorders. Am J Clin Pathol. 1993;99:385–96.Google Scholar
Knight, PJ, Mulne, AF, Vassy, LE. When is lymph node biopsy indicated in children with enlarged peripheral nodes? Pediatrics. 1982;69:391–6.Google Scholar
Aliano, D and Thomson, R. The epidemiology of extrapulmonary non-tuberculous mycobacterial infection in a pediatric population. Pediatr Infect Dis J. 2020;39:671–7.Google Scholar
Tortoli, E. Clinical manifestations of nontuberculous mycobacteria infections. Clin Microbiol Infect. 2009;15:906–10.Google Scholar
Rosenberg, TL, Nolder, AR. Pediatric cervical lymphadenopathy. Otolaryngol Clin North Am. 2014;47:721–31.Google Scholar
Talerman, A, Bradley, JM, Woodland, B. Cryptococcal lymphadenitis. J Med Microbiol. 1970;3:633–8.Google Scholar
Alsan, MM, Issa, NC, Hammond, SP, et al. Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2011;11:375–7.Google Scholar
Kuttiatt, V, Sreenivasa, P, Garg, I, et al. Cryptococcal lymphadenitis and immune reconstitution inflammatory syndrome: current considerations. Scand J Infect Diseases. 2011;43:664–8.Google Scholar
Wheat, LJ, Azar, MM, Bahr, NC, et al. Histoplasmosis. Infect Dis Clin North Am, 2016; 30:207–27.Google Scholar
Winn, WC, Koneman, EW. Koneman’s color atlas and textbook of diagnostic microbiology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.Google Scholar
Saubolle, MA, McKellar, PP, Sussland, D. Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiology. 2007;45:26–30.Google Scholar
Lindeboom, JA. Pediatric cervicofacial lymphadenitis caused by Bartonella henselae. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:469–73.Google Scholar
Proytcheva, MA. Reactive lymphadenopathies. In: Proytcheva, MA, ed. Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:142–81.Google Scholar
Barros, MH, Vera-Lozada, G, Segges, P, et al. Revisiting the tissue microenvironment of infectious mononucleosis: identification of EBV infection in T cells and deep characterization of immune profiles. Front Immunol. 2019;10:146.Google Scholar
Balfour, HH Jr, Dunmire, SK, Hogquist, KA. Infectious mononucleosis. Clin Transl Immunology. 2015;4:e33.Google Scholar
Dunmire, SK, Verghese, PS, Balfour, Jr HH. Primary Epstein-Barr virus infection. J Clin Virol. 2018;102:84–92.Google Scholar
Yagmur, G, Ziyade, N, Elgormus, N, et al. Postmortem diagnosis of cytomegalovirus and accompanying other infection agents by real-time PCR in cases of sudden unexpected death in infancy (SUDI). J Forensic Leg Med. 2016;38:18–23.Google Scholar
Gandhi, MK, Khanna, R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4:725–38.Google Scholar
Hurt, C, Tammaro, D. Diagnostic evaluation of mononucleosis-like illnesses. Am J M. 2007;120:911.e1–8.Google Scholar
French, PD, Birchall, MA, Harris, JR. Cytomegalovirus ulceration of the oropharynx. J Laryngol Otol. 1991;105:739–42.Google Scholar
Alòs, L, Navarrete, P, Morente, V, et al. Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence. Mod Pathol. 2005;18:127–36.Google Scholar
Nag, D, Dey, S, Nandi, A, et al. Etiological study of lymphadenopathy in HIV-infected patients in a tertiary care hospital. J Cytol. 2016;33:66–70.Google Scholar
Chadburn, A, Abdul-Nabi, AM, Teruya, BS, et al. Lymphoid proliferations associated with human immunodeficiency virus infection. Arch Pathol Lab Med. 2013;137:360–70.Google Scholar
Dard, C, Fricker-Hidalgo, H, Brenier-Pinchart, MP, et al. Relevance of and new developments in serology for toxoplasmosis. Trends Parasitol. 2016;32:492–506.Google Scholar